Aruna Shanbaug (2011) recognized passive euthanasia but required High Court approval for each individual case, making it a reactive and cumbersome process. It did not empower individuals to make prior decisions. Common Cause (2018) filled this critical gap by *legalizing 'Advance Directives' or 'Living Wills'*. This allows competent adults to proactively decide on their end-of-life treatment, respecting their autonomy and dignity, without needing court intervention at the time of crisis. This shift from judicial oversight to individual pre-determination is what makes it a landmark for autonomy.

The 'right to die with dignity' expands Article 21's 'Right to Life' by asserting that a dignified life includes a dignified end, especially when suffering from an irreversible condition with no hope of recovery. It recognizes that forcing someone to prolong their biological existence through artificial means, when there's no quality of life, infringes upon their dignity. However, it is *not* a 'right to die' in the sense of a right to commit suicide or demand active euthanasia. Instead, it is the right to *refuse unwanted medical treatment* that merely prolongs suffering, ensuring that the process of dying is also dignified and in line with the patient's wishes.

The judgment aimed to resolve the ethical dilemma arising from modern medicine's ability to prolong biological existence indefinitely, even when there's no hope of recovery or quality of life. This often leads to prolonged suffering for the patient, immense emotional and financial burden on families, and a loss of dignity. Common Cause (2018) sought to empower individuals with the autonomy to make choices about their end-of-life care, preventing them from being trapped in a state of 'living death' against their will, thereby upholding their fundamental right to live and die with dignity.

The Harish Rana (2026) case crucially clarified that 'Clinically Assisted Nutrition and Hydration (CANH)', such as feeding tubes, *constitutes medical treatment* and can therefore be withdrawn under the established passive euthanasia guidelines. This clarification was vital because there was ambiguity whether providing nutrition and hydration through artificial means counted as 'treatment' or basic care that could not be stopped. By confirming CANH as medical treatment, the judgment ensured that patients in persistent vegetative states, like Harish Rana, could truly exercise their right to die with dignity by allowing the withdrawal of all forms of life support, including artificial feeding.

One primary limitation is that it's a judgment-based framework, not a comprehensive law passed by Parliament. While the Supreme Court's guidelines are binding, they lack the democratic legitimacy and detailed provisions that a legislative act could provide. Critics also point to the complexity of the 'Living Will' process, even after the 2023 modification, which can still be daunting for ordinary citizens. Furthermore, the judgment does not address active euthanasia, which some argue should be considered in specific, extreme cases. The Supreme Court's repeated call for parliamentary legislation highlights these limitations, indicating that a more robust, publicly debated, and comprehensive legal framework is still needed for end-of-life care.

The key procedural safeguards for a 'Living Will' include: it must be in writing by a competent adult, attested by two independent witnesses, and countersigned by a Judicial Magistrate First Class (JMFC). These safeguards are designed to ensure that the decision is voluntary, well-informed, and made without coercion, preventing misuse or exploitation of vulnerable individuals. However, these very safeguards can pose practical challenges: finding two independent witnesses, navigating the legal formalities with a JMFC, and the overall complexity can deter many from creating a Living Will. This might lead to a situation where, despite the legal provision, few people actually utilize it, thus limiting its real-world impact.

If the Common Cause (2018) judgment had not been delivered, patients in persistent vegetative states or with terminal illnesses would largely remain without a legally recognized mechanism to refuse life-sustaining treatment. Families would continue to face immense emotional and financial distress, forced to watch their loved ones endure prolonged suffering without hope of recovery, often against what they believe would be the patient's wishes. The 'right to die with dignity' would remain largely theoretical, dependent on cumbersome, case-by-case High Court interventions (as per Aruna Shanbaug), severely limiting patient autonomy and dignity in end-of-life decisions. The legal vacuum would perpetuate a situation where medical technology dictates the end of life, rather than individual choice.

The strongest ethical argument against the 'right to die with dignity' is the 'slippery slope' concern: that legalizing passive euthanasia, even with strict safeguards, could eventually lead to the erosion of the sanctity of life, pressure on vulnerable individuals (elderly, disabled) to opt for it, or even the eventual legalization of active euthanasia. Critics fear that what begins as a right to refuse treatment might evolve into a duty to die. The judgment's framework attempts to address these concerns through multiple layers of strict safeguards: requiring 'Living Wills' to be made by competent adults without coercion, verified by witnesses and a JMFC, and for non-will cases, mandating two independent medical boards to certify the irreversible condition and lack of recovery hope. These stringent checks aim to ensure that the decision is truly voluntary and medically justified, preventing any 'slippery slope' scenario.

A parliamentary law should address several aspects to improve upon the existing guidelines. Firstly, it could simplify the 'Living Will' process, making it more accessible without compromising safeguards, perhaps by allowing notarization or simpler witness requirements. Secondly, it should clearly define the roles and liabilities of medical professionals and hospitals, providing them with legal protection when implementing Advance Directives. Thirdly, it could establish a national or state-level oversight body to standardize procedures and resolve disputes, reducing reliance on individual court interventions. Fourthly, it should include provisions for public awareness campaigns to educate citizens about their rights and the process. Lastly, it could explore the possibility of including specific conditions or diseases (like advanced dementia, as per the pending NGO petition for rabies patients) under the ambit of dignified end-of-life care, offering more clarity and inclusivity than a judgment can provide.

India's approach, while progressive in recognizing the 'right to die with dignity' and 'Living Wills', is generally more conservative and procedurally stringent compared to some Western democracies. Countries like the Netherlands, Belgium, and Canada have legalized both active and passive euthanasia, often with broader criteria and less complex administrative processes for Advance Directives. Even for passive euthanasia, some countries have more streamlined judicial or medical board review systems. India's framework, with its emphasis on multiple medical board certifications and the initial JMFC attestation (even after 2023 modification), prioritizes stringent safeguards to prevent misuse and uphold the sanctity of life, often at the cost of some practical ease. This reflects a cautious balance between individual autonomy and societal/ethical concerns, aiming to avoid the 'slippery slope' perceived in more liberal regimes.

Aruna Shanbaug (2011) recognized passive euthanasia but required High Court approval for each individual case, making it a reactive and cumbersome process. It did not empower individuals to make prior decisions. Common Cause (2018) filled this critical gap by *legalizing 'Advance Directives' or 'Living Wills'*. This allows competent adults to proactively decide on their end-of-life treatment, respecting their autonomy and dignity, without needing court intervention at the time of crisis. This shift from judicial oversight to individual pre-determination is what makes it a landmark for autonomy.

The 'right to die with dignity' expands Article 21's 'Right to Life' by asserting that a dignified life includes a dignified end, especially when suffering from an irreversible condition with no hope of recovery. It recognizes that forcing someone to prolong their biological existence through artificial means, when there's no quality of life, infringes upon their dignity. However, it is *not* a 'right to die' in the sense of a right to commit suicide or demand active euthanasia. Instead, it is the right to *refuse unwanted medical treatment* that merely prolongs suffering, ensuring that the process of dying is also dignified and in line with the patient's wishes.

The judgment aimed to resolve the ethical dilemma arising from modern medicine's ability to prolong biological existence indefinitely, even when there's no hope of recovery or quality of life. This often leads to prolonged suffering for the patient, immense emotional and financial burden on families, and a loss of dignity. Common Cause (2018) sought to empower individuals with the autonomy to make choices about their end-of-life care, preventing them from being trapped in a state of 'living death' against their will, thereby upholding their fundamental right to live and die with dignity.

The Harish Rana (2026) case crucially clarified that 'Clinically Assisted Nutrition and Hydration (CANH)', such as feeding tubes, *constitutes medical treatment* and can therefore be withdrawn under the established passive euthanasia guidelines. This clarification was vital because there was ambiguity whether providing nutrition and hydration through artificial means counted as 'treatment' or basic care that could not be stopped. By confirming CANH as medical treatment, the judgment ensured that patients in persistent vegetative states, like Harish Rana, could truly exercise their right to die with dignity by allowing the withdrawal of all forms of life support, including artificial feeding.

One primary limitation is that it's a judgment-based framework, not a comprehensive law passed by Parliament. While the Supreme Court's guidelines are binding, they lack the democratic legitimacy and detailed provisions that a legislative act could provide. Critics also point to the complexity of the 'Living Will' process, even after the 2023 modification, which can still be daunting for ordinary citizens. Furthermore, the judgment does not address active euthanasia, which some argue should be considered in specific, extreme cases. The Supreme Court's repeated call for parliamentary legislation highlights these limitations, indicating that a more robust, publicly debated, and comprehensive legal framework is still needed for end-of-life care.

The key procedural safeguards for a 'Living Will' include: it must be in writing by a competent adult, attested by two independent witnesses, and countersigned by a Judicial Magistrate First Class (JMFC). These safeguards are designed to ensure that the decision is voluntary, well-informed, and made without coercion, preventing misuse or exploitation of vulnerable individuals. However, these very safeguards can pose practical challenges: finding two independent witnesses, navigating the legal formalities with a JMFC, and the overall complexity can deter many from creating a Living Will. This might lead to a situation where, despite the legal provision, few people actually utilize it, thus limiting its real-world impact.

If the Common Cause (2018) judgment had not been delivered, patients in persistent vegetative states or with terminal illnesses would largely remain without a legally recognized mechanism to refuse life-sustaining treatment. Families would continue to face immense emotional and financial distress, forced to watch their loved ones endure prolonged suffering without hope of recovery, often against what they believe would be the patient's wishes. The 'right to die with dignity' would remain largely theoretical, dependent on cumbersome, case-by-case High Court interventions (as per Aruna Shanbaug), severely limiting patient autonomy and dignity in end-of-life decisions. The legal vacuum would perpetuate a situation where medical technology dictates the end of life, rather than individual choice.

The strongest ethical argument against the 'right to die with dignity' is the 'slippery slope' concern: that legalizing passive euthanasia, even with strict safeguards, could eventually lead to the erosion of the sanctity of life, pressure on vulnerable individuals (elderly, disabled) to opt for it, or even the eventual legalization of active euthanasia. Critics fear that what begins as a right to refuse treatment might evolve into a duty to die. The judgment's framework attempts to address these concerns through multiple layers of strict safeguards: requiring 'Living Wills' to be made by competent adults without coercion, verified by witnesses and a JMFC, and for non-will cases, mandating two independent medical boards to certify the irreversible condition and lack of recovery hope. These stringent checks aim to ensure that the decision is truly voluntary and medically justified, preventing any 'slippery slope' scenario.

A parliamentary law should address several aspects to improve upon the existing guidelines. Firstly, it could simplify the 'Living Will' process, making it more accessible without compromising safeguards, perhaps by allowing notarization or simpler witness requirements. Secondly, it should clearly define the roles and liabilities of medical professionals and hospitals, providing them with legal protection when implementing Advance Directives. Thirdly, it could establish a national or state-level oversight body to standardize procedures and resolve disputes, reducing reliance on individual court interventions. Fourthly, it should include provisions for public awareness campaigns to educate citizens about their rights and the process. Lastly, it could explore the possibility of including specific conditions or diseases (like advanced dementia, as per the pending NGO petition for rabies patients) under the ambit of dignified end-of-life care, offering more clarity and inclusivity than a judgment can provide.

India's approach, while progressive in recognizing the 'right to die with dignity' and 'Living Wills', is generally more conservative and procedurally stringent compared to some Western democracies. Countries like the Netherlands, Belgium, and Canada have legalized both active and passive euthanasia, often with broader criteria and less complex administrative processes for Advance Directives. Even for passive euthanasia, some countries have more streamlined judicial or medical board review systems. India's framework, with its emphasis on multiple medical board certifications and the initial JMFC attestation (even after 2023 modification), prioritizes stringent safeguards to prevent misuse and uphold the sanctity of life, often at the cost of some practical ease. This reflects a cautious balance between individual autonomy and societal/ethical concerns, aiming to avoid the 'slippery slope' perceived in more liberal regimes.